168 related articles for article (PubMed ID: 8183287)
1. Controversies on the role of bone marrow transplantation for patients with hematopoietic malignancies.
Geller RB
Mt Sinai J Med; 1994 Jan; 61(1):13-22. PubMed ID: 8183287
[TBL] [Abstract][Full Text] [Related]
2. [Indications, technique and risks in bone marrow transplantation in adulthood].
Heyll A; Söhngen D; Minning H; Meckenstock G; Aul C; Schneider W
Praxis (Bern 1994); 1996 Mar; 85(12):378-86. PubMed ID: 8643901
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation. The state of the art.
Thomas ED
Ann Ital Med Int; 1986 Jun; 1(2):109-14. PubMed ID: 3079358
[No Abstract] [Full Text] [Related]
4. Current status of bone marrow transplantation.
Bortin MM; Horowitz MM
Clin Transpl; 1989; ():93-104. PubMed ID: 2487630
[TBL] [Abstract][Full Text] [Related]
5. Autologous bone marrow transplantation for leukemia.
Stuart RK
Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
[TBL] [Abstract][Full Text] [Related]
6. Importance of bone marrow cell dose in bone marrow transplantation.
Paulin T
Clin Transplant; 1992 Feb; 6(1):48-54. PubMed ID: 10150090
[TBL] [Abstract][Full Text] [Related]
7. [Allogenic bone marrow transplantation in acute leukemias and chronic myeloid leukemia].
Mendeleeva LP
Ter Arkh; 2003; 75(7):89-94. PubMed ID: 12934492
[No Abstract] [Full Text] [Related]
8. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplantation at The Mount Sinai Hospital.
Fruchtman SM; Scigliano E; Ross V; Abramowitz A; Lipton J; Mandell L; Shank B
Mt Sinai J Med; 1994 Jan; 61(1):3-12. PubMed ID: 8183289
[No Abstract] [Full Text] [Related]
10. Allogeneic family-unrelated bone marrow transplantation in acute and chronic myeloid leukemia.
Fauser AA; Köchling G; Digel W; Finke J; Thiel M; Heinz J; Bross KJ; Dölken G; Mertelsmann R
Bone Marrow Transplant; 1993; 11 Suppl 1():83. PubMed ID: 8448558
[No Abstract] [Full Text] [Related]
11. Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.
Ueda M; Joshi ID; Dan M; Uberti JP; Chou TH; Sensenbrenner LL; Lum LG
Transplantation; 1993 Aug; 56(2):351-6. PubMed ID: 8356589
[TBL] [Abstract][Full Text] [Related]
12. [The role of bone marrow transplantation in the treatment of leukemia].
Robak T
Przegl Lek; 1990; 47(10):723-7. PubMed ID: 2089452
[No Abstract] [Full Text] [Related]
13. Busulfan (Bu) and cyclophosphamide (Cy) for marrow transplantation.
Santos GW
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():236-9. PubMed ID: 2653511
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation: a new treatment approach for Mississippians.
Bigelow CL; Files JC
J Miss State Med Assoc; 1991 Jun; 32(6):205-8. PubMed ID: 1870116
[TBL] [Abstract][Full Text] [Related]
15. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
16. Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry.
Nivison-Smith I; Bradstock KF; Dodds AJ; Hawkins PA; Szer J
Intern Med J; 2005 Jan; 35(1):18-27. PubMed ID: 15667464
[TBL] [Abstract][Full Text] [Related]
17. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
[TBL] [Abstract][Full Text] [Related]
18. [Indications of allogeneic bone marrow transplantation].
Kai S
Nihon Rinsho; 1990 Sep; 48(9):2003-7. PubMed ID: 2232203
[No Abstract] [Full Text] [Related]
19. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
[TBL] [Abstract][Full Text] [Related]
20. Role of bone marrow transplantation in the treatment of hematologic malignancies and solid tumors: critical review of syngeneic, autologous, and allogeneic transplants.
Champlin RE; Gale RP
Cancer Treat Rep; 1984 Jan; 68(1):145-61. PubMed ID: 6362862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
